ArticleTherapeutic advances in medical oncology2026
Homologous recombination deficiency correlates with tumor-infiltrating lymphocytes and predicts patient outcomes in hormone receptor-positive/HER2-negative breast cancer.
Shu-Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.